200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 19794-97-9

19794-97-9

19794-97-9 | 1,3-Octadecanediol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R)-

CAS No: 19794-97-9 Catalog No: AG002B6V MDL No:

Product Description

Catalog Number:
AG002B6V
Chemical Name:
1,3-Octadecanediol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R)-
CAS Number:
19794-97-9
Molecular Formula:
C18H40NO5P
Molecular Weight:
381.4877
IUPAC Name:
[(2S,3R)-2-amino-3-hydroxyoctadecyl] dihydrogen phosphate
InChI:
InChI=1S/C18H40NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h17-18,20H,2-16,19H2,1H3,(H2,21,22,23)/t17-,18+/m0/s1
InChI Key:
YHEDRJPUIRMZMP-ZWKOTPCHSA-N
SMILES:
CCCCCCCCCCCCCCCC(C(COP(=O)(O)O)N)O

Properties

Complexity:
337  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
381.264g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
381.494g/mol
Monoisotopic Mass:
381.264g/mol
Rotatable Bond Count:
18  
Topological Polar Surface Area:
113A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.4  

Literature

Title Journal
A strategy for enrichment of the bioactive sphingoid base-1-phosphates produced by Hypericum perforatum L. in a balloon type airlift reactor. Bioresource technology 20121101
Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. Basic research in cardiology 20121101
Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720. Birth defects research. Part A, Clinical and molecular teratology 20121001
Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. Journal of lipid research 20120801
Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells. Neuropharmacology 20120201
Exercise increases plasma levels of sphingoid base-1 phosphates in humans. Acta physiologica (Oxford, England) 20111101
Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. Analytical and bioanalytical chemistry 20110501
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids in health and disease 20110101
UPLC-MS/MS method for analysis of sphingosine 1-phosphate in biological samples. Prostaglandins & other lipid mediators 20100901
Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Laboratory investigation; a journal of technical methods and pathology 20100801
Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. Arthritis and rheumatism 20100701
Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. Medical science monitor : international medical journal of experimental and clinical research 20090901
High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clinical chemistry 20090601
FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. The Journal of biological chemistry 20090227
Sphingosine 1-phosphate modulates spinal nociceptive processing. The Journal of biological chemistry 20081121
Human cytomegalovirus regulates bioactive sphingolipids. The Journal of biological chemistry 20080919
Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway. The Journal of biological chemistry 20080711
Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. Thrombosis and haemostasis 20080701
Involvement of sphingoid bases in mediating reactive oxygen intermediate production and programmed cell death in Arabidopsis. Cell research 20071201
Validation of fumonisin biomarkers in F344 rats. Toxicology and applied pharmacology 20071115
Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice. Archives of pharmacal research 20070801
Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. Neurochemical research 20070101
Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. Journal of thrombosis and haemostasis : JTH 20061201
Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice. Journal of toxicology and environmental health. Part A 20061201
LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. Prostaglandins & other lipid mediators 20061201
De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. Cellular signalling 20061001
Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach. Journal of lipid research 20060801
Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. Chemico-biological interactions 20060310
Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060101
Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. Journal of neurochemistry 20051201
Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors. The Biochemical journal 20050701
Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Analytical biochemistry 20050401
Pharmacological characterization of human S1P4 using a novel radioligand, [4,5-3H]-dihydrosphingosine-1-phosphate. British journal of pharmacology 20040701
Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B). Hypertension (Dallas, Tex. : 1979) 20040501
Comparative analysis of functional assays for characterization of agonist ligands at G protein-coupled receptors. Journal of biomolecular screening 20031001
Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. The Journal of biological chemistry 20030905
Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. The Journal of biological chemistry 20030829
Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry. Cellular and molecular biology (Noisy-le-Grand, France) 20030701
Transmembrane topology of sphingoid long-chain base-1-phosphate phosphatase, Lcb3p. Genes to cells : devoted to molecular & cellular mechanisms 20030601
Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. Cellular signalling 20030401
Syntheses of sphingosine-1-phosphate stereoisomers and analogues and their interaction with EDG receptors. Bioorganic & medicinal chemistry letters 20030120
Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes to cells : devoted to molecular & cellular mechanisms 20021201
Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cellular signalling 20021101
Phytosphingosine 1-phosphate: a high affinity ligand for the S1P(4)/Edg-6 receptor. Biochemical and biophysical research communications 20020927
Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. The Journal of biological chemistry 20020322
[Biologically effective sphingolipids devoid of 4-trans-double bond in the sphingoid hydrocarbon chain]. Bioorganicheskaia khimiia 20020101
Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. The Biochemical journal 20010101
Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. The Journal of biological chemistry 20000512
Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 20000415
Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. The Journal of biological chemistry 19990702
EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. The Journal of biological chemistry 19981016

Related Products

© 2019 Angene International Limited. All rights Reserved.